MedPath

NORIVIT (bebas gula)

Registration Number: MAL09062163X

Approved
Approval ID

789bb91e0415872e

Registration Number

MAL09062163X

Registration Date

Jul 4, 2025

Regulatory Authority
NPRA
Malaysia

Product Information

Additional product specifications and packaging information as registered with NPRA Malaysia.

Product Specifications

PRODUCT SPECIFICATIONS

Official SourceNPRA Database
Available Package Types4 types
Last UpdatedJul 4, 2025

PACKAGING INFORMATION (4)

100Tablet TabletsAvailable
Package Size: 100Tablet Tablets
Status: NPRA Approved
10Tablet TabletsAvailable
Package Size: 10Tablet Tablets
Status: NPRA Approved
60Tablet TabletsAvailable
Package Size: 60Tablet Tablets
Status: NPRA Approved
30Tablet TabletsAvailable
Package Size: 30Tablet Tablets
Status: NPRA Approved

Active Ingredients

Active pharmaceutical ingredients contained in this NPRA-approved product.

Ingredients (24)

BiotinActive
Monograph: Biotin
Calcium PantothenateActive
Monograph: 泛酸钙
NiacinamideActive
Monograph: 烟酰胺
BETA CAROTENEActive
THIAMINE MONONITRATEActive
Monograph: 硝酸硫胺
VITAMIN D3Active
Monograph: 维生素D3
Sodium Ascorbate.Active
Monograph: sodium ascorbate.
Ascorbic acid.Active
Monograph: ascorbic acid.
CyanocobalaminActive
Monograph: 维生素B12
Magnesium OxideActive
Monograph: Magnesium oxide
Pyridoxine hydrochlorideActive
Monograph: 维生素B6
RiboflavinActive
Monograph: 维生素B2
MANGANESE SULPHATEActive
Monograph: manganese sulphate
Zinc OxideActive
Monograph: 氧化锌
Calcium CarbonateActive
Monograph: 碳酸钙
Potassium iodideActive
Monograph: 碘化钾
FERROUS FUMARATEActive
Monograph: 富马酸亚铁
VITAMIN AActive
Monograph: 维生素A
Sodium MolybdateActive
Monograph: Sodium molybdate
SELENIUM YEASTActive
Monograph: Selenious acid
VITAMIN E ACETATEActive
Folic acid.Active
Monograph: folic acid.
Chromium Polynicotinate.Active
Monograph: chromium polynicotinate.
COPPER OXIDEActive
Monograph: copper oxide

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NORIVIT (bebas gula) - NPRA Drug Approval Details | MedPath - Medical Intelligence Platform